Hilbert Group
STOCKHOLM, SE / ACCESSWIRE / January 3, 2022 / Hilbert Group (STO:HILB-B)(FRA:999)
Hilbert Group AB (NASDAQ FN: HILB B), the Nasdaq First North listed investment firm focusing on digital assets and blockchain technology, has now launched the envisaged Hilbert Syrius Bit+ Fund ("HSBF" or the "Fund"), a systematic quant-driven crypto fund.
HSBF is launched as a joint venture with strategic advisory firm Oracle Strategies Limited under a newly formed Cayman-based investment manager named Hilbert Syrius Asset Management Ltd. Both the fund and the investment manager will be regulated by CIMA.
"The objective of HSBF is to outperform Bitcoin on a long term, risk-adjusted, basis. In order to attract institutional investors, HSBF will focus mainly on liquid, large-cap cryptocurrencies such as Bitcoin and Ethereum, with only a very limited exposure to a few top Altcoins. The core strategy is powered by Oracle Strategies' AI-based algorithms that adjust the risk-exposure according to the inherent cycles within cryptocurrencies", says Niclas Sandstrom, CEO of Hilbert Group. "The purpose of this fund launch is threefold - firstly, it broadens our fund offering with a product that is lower risk than Hilbert Digital Asset Fund. Secondly, it further expands Hilbert Group's footprint in Asia and our capacity to attract both professional and institutional investors there. And thirdly, it adds another important building block in our strategic partnership with Oracle Strategies Limited, a quantitative research firms in the hedge fund space.
"The launch of HSBF is the first in a planned series of joint fund launches and we look forward to working closely together with Hilbert Group on these. Oracle Strategies Limited have years of experience in developing bespoke trading algorithms in both cryptocurrencies and equities in order to help hedge funds outperform. We see many synergies with Hilbert Group's institutional crypto funds platform. Their expertise in crypto fund management in combination with being a public company will be of great help expanding the franchise for both parties going forward", says Joseph Jeong of Oracle Strategies Limited.
About Oracle Strategies Limited
Oracle Strategies is a private quantitative research firm that specializes in building AI-based algorithmic strategies for the hedge fund- and crypto communities. Since 2015, Oracle strategies have developed many robo-trading strategies for global equities, futures and cryptocurrency markets. Oracle Strategies' algorithms have powered winning hedge fund strategies and have helped funds significantly outperform the markets over time.
For further information, please contact:
Niclas Sandström, CEO Hilbert Group
+46 (0)8 502 353 00
ir@hilbert.group
About Us
Hilbert Group AB is an investment firm with sole focus on digital assets, primarily cryptocurrencies and blockchain technologies. The business model is diversified into four verticals - asset management, proprietary trading, equity investments and data & analytics.
Hilbert Group's vision is to be a world class digital asset investment firm with the ambition to provide first class services to its clients and shareholders, to help accelerate the technological revolution that is digital assets, and to expand people's knowledge of this emerging asset class.
Hilbert Group is listed on Nasdaq First North Growth Market (ticker HILB B) with Eminova Fondkommission (phone +46 8 684 211 10 | adviser@eminova.se ) as Certified Adviser.
Attachments
Hilbert Group launches new systematic crypto fund with focus on Bitcoin and Ethereum
SOURCE: Hilbert Group
View source version on accesswire.com:
https://www.accesswire.com/680590/Hilbert-Group-Launches-New-Systematic-Crypto-Fund-with-Focus-on-Bitcoin-and-Ethereum
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Formerra to Supply Foster Medical Compounds Across the Americas15.7.2025 16:45:00 CEST | Press release
Following GEON's acquisition of Foster, LLC, this new agreement expands Formerra's healthcare polymer portfolio with life-saving medical compounds. ROMEOVILLE, IL / ACCESS Newswire / July 15, 2025 / Formerra, a leader in performance materials distribution, today announced an agreement with GEON® Performance Solutions that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in North America and South America. The agreement follows GEON's acquisition of Foster, LLC, and builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials. "This expanded partnership equips our customers with a broader set of proven medical-grade solutions while leveraging Formerra's technical guidance and robust supply-chain capabilities," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Foster's brand strength and GEON's investment momentum create powerful growth potential for these materials and our cust
FairWinds Migrates from .COM to .FAIRWINDS, Showcasing Leadership in Strategic Internet Addressing15.7.2025 16:00:00 CEST | Press release
WASHINGTON, DC / ACCESS Newswire / July 15, 2025 / FairWinds Partners, the world's leading domain name strategy consultancy, has completed the migration of its website from fairwindspartners.com to home.fairwinds. "This transition is more than a domain change. It reflects our belief in the future of .BRAND top-level domains," said FairWinds founder Josh Bourne. "Our move to .FAIRWINDS reinforces the strategic value that these top-level domains offer and our evolution from a pioneering domain name advisory firm to the trusted partner for global brands navigating the digital landscape via the address bar." Unlike second-level domains like google.com, top-level domains reside on the internet's root servers -- the foundation of the internet's naming system. .BRAND top-level domains are not publicly available and are used exclusively by the brand owner. ".BRAND top-level domains provide a powerful way to amplify, control, and secure a brand's digital presence while giving visitors visual pr
QorusDocs Reports 360% Increase in Customers Using AI to Manage Proposals, Acquires Shark Finesse to Build Unified AI-Powered Value and Proposal Platform15.7.2025 13:00:00 CEST | Press release
BELLEVUE, WA / ACCESS Newswire / July 15, 2025 / QorusDocs, an AI-powered proposal management software company that streamlines creation of pitches, proposals and request for proposal (RFP) responses, today announced that its customers' use of AI to manage proposals has grown 360% year over year, and that it has acquired Shark Finesse Ltd, a United Kingdom-based AI-powered customer value management software. "AI is completely transforming how business development teams win business, and QorusDocs is at the forefront," said Ray Meiring, CEO of QorusDocs. "The majority of our customers now rely on AI to manage proposals. We're at a pivotal moment, and with the acquisition of Shark Finesse, we're poised to deliver on companies' full revenue enablement journey, from proving value to winning the deal." QorusDocs Acquires Shark Finesse With Shark Finesse joining QorusDocs, the company's vision is to enable business development and proposal teams to prove value early in the revenue cycle, wit
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease15.7.2025 09:50:00 CEST | Press release
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action VILNIUS, LT / ACCESS Newswire / July 15, 2025 / AATec Medical GmbH ("AATec"), a biotech company developing a multi-product platform for the treatment of respiratory diseases, and Northway Biotech ("Northway Biotech" or "NBT"), a global Contract Development and Manufacturing Organization (CDMO), today announced a partnership for manufacturing process development and analytical development of AATec's lead product candidate, ATL-105, a proprietary, inhaled therapy based on recombinant alpha-1 antitrypsin (AAT) for non-cystic fibrosis bronchiectasis (NCFB).AATec Medical and Northway Biotech Announce Partnership Under the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop and scale the production process for ATL-
IXOPAY Surges Past 500 Certified Adapters, Solidifies Leadership in Enterprise-Grade Payment Orchestration15.7.2025 06:00:00 CEST | Press release
With 200 PSPs and 300 payment methods, IXOPAY is unlocking faster global expansion, improved approval rates, and full-stack control for enterprise merchants. LEHI, UT / ACCESS Newswire / July 15, 2025 / As global commerce accelerates, enterprise merchants are hitting a wall - their legacy payment stacks weren't built for the scale, complexity, or speed modern commerce demands. To stay competitive, merchants need infrastructure that adapts across markets, providers, and payment methods without costly rewrites or vendor lock-in. IXOPAY, a global leader in enterprise-grade payment orchestration, is addressing that challenge head-on with the announcement it has reached 500 certified adapters, connecting 200 payment service providers (PSPs) and 300 payment methods through a single, vendor-agnostic API. Payment orchestration is rapidly emerging as vital infrastructure for modern payments, and its effectiveness depends on the scale and breadth of the adapter ecosystem. IXOPAY's industry-leadi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom